Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients

Thromb Res. 2002 Mar 15;105(6):471-6. doi: 10.1016/s0049-3848(02)00053-1.

Abstract

von Willebrand factor (vWF) multimeric pattern and von Willebrand factor-cleaving protease activity (vWF-cp) were studied using plasmas from patients with advanced stage- and limited stage-malignant tumors. Deficiency of highly polymeric forms of vWF was observed in plasmas from 7 of 11 patients tested. vWF-cp activity was deficient in plasma samples of six patients with advanced stage-malignant tumors (ranging from 6% to 30% activity of normal plasma), whereas an essentially normal vWF-cp activity was observed in samples taken from patients with limited stage-malignant tumors. Inhibitor of vWF-cp was not detected in any plasma samples tested. To further analyze the relevance of this enzymatic activity in metastatic diagnosis, a study of vWF-cp activity was conducted in 17 patients with colon cancer, and it was shown that deficiency of vWF-cp was associated with the progression of the disease.

MeSH terms

  • ADAM Proteins
  • ADAMTS13 Protein
  • Adult
  • Aged
  • Colonic Neoplasms / blood
  • Colonic Neoplasms / enzymology
  • Colonic Neoplasms / pathology
  • Dimerization
  • Disease Progression
  • Female
  • Humans
  • Male
  • Metalloendopeptidases / blood
  • Metalloendopeptidases / deficiency*
  • Middle Aged
  • Neoplasm Metastasis / diagnosis
  • Neoplasms / blood*
  • Neoplasms / enzymology
  • Neoplasms / pathology
  • von Willebrand Factor / metabolism

Substances

  • von Willebrand Factor
  • ADAM Proteins
  • Metalloendopeptidases
  • ADAMTS13 Protein
  • ADAMTS13 protein, human